Copyright Reports & Markets. All rights reserved.

Global Metformin Hydrochloride Sustained-release Tablets Supply, Demand and Key Producers, 2023-2029

Request for Sample of this report
Buy now

1 Supply Summary

  • 1.1 Metformin Hydrochloride Sustained-release Tablets Introduction
  • 1.2 World Metformin Hydrochloride Sustained-release Tablets Supply & Forecast
    • 1.2.1 World Metformin Hydrochloride Sustained-release Tablets Production Value (2018 & 2022 & 2029)
    • 1.2.2 World Metformin Hydrochloride Sustained-release Tablets Production (2018-2029)
    • 1.2.3 World Metformin Hydrochloride Sustained-release Tablets Pricing Trends (2018-2029)
  • 1.3 World Metformin Hydrochloride Sustained-release Tablets Production by Region (Based on Production Site)
    • 1.3.1 World Metformin Hydrochloride Sustained-release Tablets Production Value by Region (2018-2029)
    • 1.3.2 World Metformin Hydrochloride Sustained-release Tablets Production by Region (2018-2029)
    • 1.3.3 World Metformin Hydrochloride Sustained-release Tablets Average Price by Region (2018-2029)
    • 1.3.4 North America Metformin Hydrochloride Sustained-release Tablets Production (2018-2029)
    • 1.3.5 Europe Metformin Hydrochloride Sustained-release Tablets Production (2018-2029)
    • 1.3.6 China Metformin Hydrochloride Sustained-release Tablets Production (2018-2029)
    • 1.3.7 Japan Metformin Hydrochloride Sustained-release Tablets Production (2018-2029)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Metformin Hydrochloride Sustained-release Tablets Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Metformin Hydrochloride Sustained-release Tablets Major Market Trends
  • 1.5 Influence of COVID-19 and Russia-Ukraine War
    • 1.5.1 Influence of COVID-19
    • 1.5.2 Influence of Russia-Ukraine War

2 Demand Summary

  • 2.1 World Metformin Hydrochloride Sustained-release Tablets Demand (2018-2029)
  • 2.2 World Metformin Hydrochloride Sustained-release Tablets Consumption by Region
    • 2.2.1 World Metformin Hydrochloride Sustained-release Tablets Consumption by Region (2018-2023)
    • 2.2.2 World Metformin Hydrochloride Sustained-release Tablets Consumption Forecast by Region (2024-2029)
  • 2.3 United States Metformin Hydrochloride Sustained-release Tablets Consumption (2018-2029)
  • 2.4 China Metformin Hydrochloride Sustained-release Tablets Consumption (2018-2029)
  • 2.5 Europe Metformin Hydrochloride Sustained-release Tablets Consumption (2018-2029)
  • 2.6 Japan Metformin Hydrochloride Sustained-release Tablets Consumption (2018-2029)
  • 2.7 South Korea Metformin Hydrochloride Sustained-release Tablets Consumption (2018-2029)
  • 2.8 ASEAN Metformin Hydrochloride Sustained-release Tablets Consumption (2018-2029)
  • 2.9 India Metformin Hydrochloride Sustained-release Tablets Consumption (2018-2029)

3 World Metformin Hydrochloride Sustained-release Tablets Manufacturers Competitive Analysis

  • 3.1 World Metformin Hydrochloride Sustained-release Tablets Production Value by Manufacturer (2018-2023)
  • 3.2 World Metformin Hydrochloride Sustained-release Tablets Production by Manufacturer (2018-2023)
  • 3.3 World Metformin Hydrochloride Sustained-release Tablets Average Price by Manufacturer (2018-2023)
  • 3.4 Metformin Hydrochloride Sustained-release Tablets Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Metformin Hydrochloride Sustained-release Tablets Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Metformin Hydrochloride Sustained-release Tablets in 2022
    • 3.5.3 Global Concentration Ratios (CR8) for Metformin Hydrochloride Sustained-release Tablets in 2022
  • 3.6 Metformin Hydrochloride Sustained-release Tablets Market: Overall Company Footprint Analysis
    • 3.6.1 Metformin Hydrochloride Sustained-release Tablets Market: Region Footprint
    • 3.6.2 Metformin Hydrochloride Sustained-release Tablets Market: Company Product Type Footprint
    • 3.6.3 Metformin Hydrochloride Sustained-release Tablets Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Metformin Hydrochloride Sustained-release Tablets Production Value Comparison
    • 4.1.1 United States VS China: Metformin Hydrochloride Sustained-release Tablets Production Value Comparison (2018 & 2022 & 2029)
    • 4.1.2 United States VS China: Metformin Hydrochloride Sustained-release Tablets Production Value Market Share Comparison (2018 & 2022 & 2029)
  • 4.2 United States VS China: Metformin Hydrochloride Sustained-release Tablets Production Comparison
    • 4.2.1 United States VS China: Metformin Hydrochloride Sustained-release Tablets Production Comparison (2018 & 2022 & 2029)
    • 4.2.2 United States VS China: Metformin Hydrochloride Sustained-release Tablets Production Market Share Comparison (2018 & 2022 & 2029)
  • 4.3 United States VS China: Metformin Hydrochloride Sustained-release Tablets Consumption Comparison
    • 4.3.1 United States VS China: Metformin Hydrochloride Sustained-release Tablets Consumption Comparison (2018 & 2022 & 2029)
    • 4.3.2 United States VS China: Metformin Hydrochloride Sustained-release Tablets Consumption Market Share Comparison (2018 & 2022 & 2029)
  • 4.4 United States Based Metformin Hydrochloride Sustained-release Tablets Manufacturers and Market Share, 2018-2023
    • 4.4.1 United States Based Metformin Hydrochloride Sustained-release Tablets Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Metformin Hydrochloride Sustained-release Tablets Production Value (2018-2023)
    • 4.4.3 United States Based Manufacturers Metformin Hydrochloride Sustained-release Tablets Production (2018-2023)
  • 4.5 China Based Metformin Hydrochloride Sustained-release Tablets Manufacturers and Market Share
    • 4.5.1 China Based Metformin Hydrochloride Sustained-release Tablets Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Metformin Hydrochloride Sustained-release Tablets Production Value (2018-2023)
    • 4.5.3 China Based Manufacturers Metformin Hydrochloride Sustained-release Tablets Production (2018-2023)
  • 4.6 Rest of World Based Metformin Hydrochloride Sustained-release Tablets Manufacturers and Market Share, 2018-2023
    • 4.6.1 Rest of World Based Metformin Hydrochloride Sustained-release Tablets Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Tablets Production Value (2018-2023)
    • 4.6.3 Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Tablets Production (2018-2023)

5 Market Analysis by Type

  • 5.1 World Metformin Hydrochloride Sustained-release Tablets Market Size Overview by Type: 2018 VS 2022 VS 2029
  • 5.2 Segment Introduction by Type
    • 5.2.1 0.5g
    • 5.2.2 0.25g
  • 5.3 Market Segment by Type
    • 5.3.1 World Metformin Hydrochloride Sustained-release Tablets Production by Type (2018-2029)
    • 5.3.2 World Metformin Hydrochloride Sustained-release Tablets Production Value by Type (2018-2029)
    • 5.3.3 World Metformin Hydrochloride Sustained-release Tablets Average Price by Type (2018-2029)

6 Market Analysis by Application

  • 6.1 World Metformin Hydrochloride Sustained-release Tablets Market Size Overview by Application: 2018 VS 2022 VS 2029
  • 6.2 Segment Introduction by Application
    • 6.2.1 Hospital
    • 6.2.2 Clinic
    • 6.2.3 Other
  • 6.3 Market Segment by Application
    • 6.3.1 World Metformin Hydrochloride Sustained-release Tablets Production by Application (2018-2029)
    • 6.3.2 World Metformin Hydrochloride Sustained-release Tablets Production Value by Application (2018-2029)
    • 6.3.3 World Metformin Hydrochloride Sustained-release Tablets Average Price by Application (2018-2029)

7 Company Profiles

  • 7.1 Merck
    • 7.1.1 Merck Details
    • 7.1.2 Merck Major Business
    • 7.1.3 Merck Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.1.4 Merck Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.1.5 Merck Recent Developments/Updates
    • 7.1.6 Merck Competitive Strengths & Weaknesses
  • 7.2 Viatris
    • 7.2.1 Viatris Details
    • 7.2.2 Viatris Major Business
    • 7.2.3 Viatris Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.2.4 Viatris Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.2.5 Viatris Recent Developments/Updates
    • 7.2.6 Viatris Competitive Strengths & Weaknesses
  • 7.3 Apotex
    • 7.3.1 Apotex Details
    • 7.3.2 Apotex Major Business
    • 7.3.3 Apotex Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.3.4 Apotex Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.3.5 Apotex Recent Developments/Updates
    • 7.3.6 Apotex Competitive Strengths & Weaknesses
  • 7.4 Teva Pharmaceuticals
    • 7.4.1 Teva Pharmaceuticals Details
    • 7.4.2 Teva Pharmaceuticals Major Business
    • 7.4.3 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.4.4 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.4.5 Teva Pharmaceuticals Recent Developments/Updates
    • 7.4.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
  • 7.5 Sun Pharmaceutical Industries
    • 7.5.1 Sun Pharmaceutical Industries Details
    • 7.5.2 Sun Pharmaceutical Industries Major Business
    • 7.5.3 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.5.4 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
    • 7.5.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
  • 7.6 Dr. Reddy's Laboratories
    • 7.6.1 Dr. Reddy's Laboratories Details
    • 7.6.2 Dr. Reddy's Laboratories Major Business
    • 7.6.3 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.6.4 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
    • 7.6.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
  • 7.7 Qingdao Huanghai Pharmaceutical
    • 7.7.1 Qingdao Huanghai Pharmaceutical Details
    • 7.7.2 Qingdao Huanghai Pharmaceutical Major Business
    • 7.7.3 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.7.4 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.7.5 Qingdao Huanghai Pharmaceutical Recent Developments/Updates
    • 7.7.6 Qingdao Huanghai Pharmaceutical Competitive Strengths & Weaknesses
  • 7.8 CTTQ
    • 7.8.1 CTTQ Details
    • 7.8.2 CTTQ Major Business
    • 7.8.3 CTTQ Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.8.4 CTTQ Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.8.5 CTTQ Recent Developments/Updates
    • 7.8.6 CTTQ Competitive Strengths & Weaknesses
  • 7.9 Shanghai Pharmaceuticals
    • 7.9.1 Shanghai Pharmaceuticals Details
    • 7.9.2 Shanghai Pharmaceuticals Major Business
    • 7.9.3 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.9.4 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.9.5 Shanghai Pharmaceuticals Recent Developments/Updates
    • 7.9.6 Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
  • 7.10 Tianan Pharmaceutical
    • 7.10.1 Tianan Pharmaceutical Details
    • 7.10.2 Tianan Pharmaceutical Major Business
    • 7.10.3 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.10.4 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.10.5 Tianan Pharmaceutical Recent Developments/Updates
    • 7.10.6 Tianan Pharmaceutical Competitive Strengths & Weaknesses
  • 7.11 Chongqing Conquer Pharmaceutical
    • 7.11.1 Chongqing Conquer Pharmaceutical Details
    • 7.11.2 Chongqing Conquer Pharmaceutical Major Business
    • 7.11.3 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.11.4 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.11.5 Chongqing Conquer Pharmaceutical Recent Developments/Updates
    • 7.11.6 Chongqing Conquer Pharmaceutical Competitive Strengths & Weaknesses
  • 7.12 CSPC
    • 7.12.1 CSPC Details
    • 7.12.2 CSPC Major Business
    • 7.12.3 CSPC Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.12.4 CSPC Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.12.5 CSPC Recent Developments/Updates
    • 7.12.6 CSPC Competitive Strengths & Weaknesses
  • 7.13 Jingfeng Pharmaceutical Group
    • 7.13.1 Jingfeng Pharmaceutical Group Details
    • 7.13.2 Jingfeng Pharmaceutical Group Major Business
    • 7.13.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.13.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.13.5 Jingfeng Pharmaceutical Group Recent Developments/Updates
    • 7.13.6 Jingfeng Pharmaceutical Group Competitive Strengths & Weaknesses
  • 7.14 Topfond Pharmaceutical
    • 7.14.1 Topfond Pharmaceutical Details
    • 7.14.2 Topfond Pharmaceutical Major Business
    • 7.14.3 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.14.4 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.14.5 Topfond Pharmaceutical Recent Developments/Updates
    • 7.14.6 Topfond Pharmaceutical Competitive Strengths & Weaknesses
  • 7.15 SinocorpPharma
    • 7.15.1 SinocorpPharma Details
    • 7.15.2 SinocorpPharma Major Business
    • 7.15.3 SinocorpPharma Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.15.4 SinocorpPharma Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.15.5 SinocorpPharma Recent Developments/Updates
    • 7.15.6 SinocorpPharma Competitive Strengths & Weaknesses
  • 7.16 Jiangsu Deyuan Pharmaceutical
    • 7.16.1 Jiangsu Deyuan Pharmaceutical Details
    • 7.16.2 Jiangsu Deyuan Pharmaceutical Major Business
    • 7.16.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product and Services
    • 7.16.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Production, Price, Value, Gross Margin and Market Share (2018-2023)
    • 7.16.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
    • 7.16.6 Jiangsu Deyuan Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Metformin Hydrochloride Sustained-release Tablets Industry Chain
  • 8.2 Metformin Hydrochloride Sustained-release Tablets Upstream Analysis
    • 8.2.1 Metformin Hydrochloride Sustained-release Tablets Core Raw Materials
    • 8.2.2 Main Manufacturers of Metformin Hydrochloride Sustained-release Tablets Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Metformin Hydrochloride Sustained-release Tablets Production Mode
  • 8.6 Metformin Hydrochloride Sustained-release Tablets Procurement Model
  • 8.7 Metformin Hydrochloride Sustained-release Tablets Industry Sales Model and Sales Channels
    • 8.7.1 Metformin Hydrochloride Sustained-release Tablets Sales Model
    • 8.7.2 Metformin Hydrochloride Sustained-release Tablets Typical Customers

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    The global Metformin Hydrochloride Sustained-release Tablets market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
    Metformin hydrochloride sustained-release tablet is a medication used to treat type 2 diabetes. It is a long-acting form of metformin, which helps to lower blood sugar levels by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin.
    This report studies the global Metformin Hydrochloride Sustained-release Tablets production, demand, key manufacturers, and key regions.
    This report is a detailed and comprehensive analysis of the world market for Metformin Hydrochloride Sustained-release Tablets, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Metformin Hydrochloride Sustained-release Tablets that contribute to its increasing demand across many markets.
    Highlights and key features of the study
    Global Metformin Hydrochloride Sustained-release Tablets total production and demand, 2018-2029, (K Units)
    Global Metformin Hydrochloride Sustained-release Tablets total production value, 2018-2029, (USD Million)
    Global Metformin Hydrochloride Sustained-release Tablets production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
    Global Metformin Hydrochloride Sustained-release Tablets consumption by region & country, CAGR, 2018-2029 & (K Units)
    U.S. VS China: Metformin Hydrochloride Sustained-release Tablets domestic production, consumption, key domestic manufacturers and share
    Global Metformin Hydrochloride Sustained-release Tablets production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
    Global Metformin Hydrochloride Sustained-release Tablets production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
    Global Metformin Hydrochloride Sustained-release Tablets production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
    This reports profiles key players in the global Metformin Hydrochloride Sustained-release Tablets market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Viatris, Apotex, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Qingdao Huanghai Pharmaceutical, CTTQ and Shanghai Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Metformin Hydrochloride Sustained-release Tablets market
    Detailed Segmentation:
    Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
    Global Metformin Hydrochloride Sustained-release Tablets Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World
    Global Metformin Hydrochloride Sustained-release Tablets Market, Segmentation by Type
    0.5g
    0.25g
    Global Metformin Hydrochloride Sustained-release Tablets Market, Segmentation by Application
    Hospital
    Clinic
    Other
    Companies Profiled:
    Merck
    Viatris
    Apotex
    Teva Pharmaceuticals
    Sun Pharmaceutical Industries
    Dr. Reddy's Laboratories
    Qingdao Huanghai Pharmaceutical
    CTTQ
    Shanghai Pharmaceuticals
    Tianan Pharmaceutical
    Chongqing Conquer Pharmaceutical
    CSPC
    Jingfeng Pharmaceutical Group
    Topfond Pharmaceutical
    SinocorpPharma
    Jiangsu Deyuan Pharmaceutical
    Key Questions Answered
    1. How big is the global Metformin Hydrochloride Sustained-release Tablets market?
    2. What is the demand of the global Metformin Hydrochloride Sustained-release Tablets market?
    3. What is the year over year growth of the global Metformin Hydrochloride Sustained-release Tablets market?
    4. What is the production and production value of the global Metformin Hydrochloride Sustained-release Tablets market?
    5. Who are the key producers in the global Metformin Hydrochloride Sustained-release Tablets market?
    6. What are the growth factors driving the market demand?

    Buy now